Purchases and Sales Made in Q3 2023 in Alpine Immune Sciences, Inc. (ALPN)
This table provides information about the institutional ownership of Alpine Immune Sciences, Inc. (ALPN) during Q3 2023. The information is specifically focused on institutions that hold shares of ALPINE IMMUNE SCIENCES, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Oct 25, 2023
Q3 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Oct 30, 2023
Q3 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Nov 07, 2023
Q3 2023
|
Dorsey Wright & Associates
|
SELL
|
- |
-78- 3.32% |
$790 - $1.09K
|
2.27K
$0
|
|
|
Nov 14, 2023
Q3 2023
|
Moore Capital Management, LP
New York, NY |
SELL
|
- |
-100- 0.72% |
$1.01K - $1.4K
|
13.7K
$0
|
|
|
Nov 14, 2023
Q3 2023
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-292- 0.31% |
$2.96K - $4.08K
|
93.4K
$0
|
|
|
Nov 13, 2023
Q3 2023
|
Connor, Clark & Lunn Investment Management Ltd.
|
SELL
|
- |
-1.12K- 2.4% |
$11.3K - $15.6K
|
45.5K
$0
|
|
|
Nov 14, 2023
Q3 2023
|
Paradigm Biocapital Advisors LP
New York, NY |
SELL
|
- |
-2.22K- 0.09% |
$22.5K - $31K
|
2.42M
$0
|
|
|
Nov 13, 2023
Q3 2023
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-5.65K- 44.52% |
$57.2K - $78.9K
|
7.04K
$0
|
|
|
Nov 09, 2023
Q3 2023
|
Citigroup Inc
|
SELL
|
- |
-9.61K- 93.48% |
$97.3K - $134K
|
670
$0
|
|
|
Nov 13, 2023
Q3 2023
|
Trexquant Investment LP
Stamford, CT |
SELL
|
- |
-14.2K- 33.19% |
$144K - $198K
|
28.6K
$0
|
|
|
Nov 14, 2023
Q3 2023
|
Tri Locum Partners LP
New York, NY |
SELL
|
- |
-18K- 5.41% |
$182K - $251K
|
314K
$0
|
|
|
Nov 14, 2023
Q3 2023
|
Sphera Funds Management Ltd.
Tel Aviv, L3 |
SELL
|
- |
-20K- 10.0% |
$203K - $280K
|
180K
$0
|
|
|
Nov 14, 2023
Q3 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-25.5K- 47.56% |
$259K - $357K
|
28.2K
$0
|
|
|
Nov 09, 2023
Q3 2023
|
Ubs Group Ag
|
SELL
|
- |
-26.8K- 58.46% |
$272K - $375K
|
19K
$0
|
|
|
Nov 14, 2023
Q3 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-31.1K- 9.74% |
$315K - $435K
|
288K
$0
|
|
|
Nov 14, 2023
Q3 2023
|
High Vista Strategies LLC
Boston, MA |
SELL
|
- |
-50.4K- 55.85% |
$511K - $705K
|
39.9K
$0
|
|
|
Nov 09, 2023
Q3 2023
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-110K- 86.25% |
$1.11M - $1.54M
|
17.5K
$0
|
|
|
May 14, 2024
Q3 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-131K- 66.43% |
$1.33M - $1.84M
|
66.4K
$0
|
|
|
Nov 14, 2023
Q3 2023
|
Lynx1 Capital Management LP
San Juan, PR |
SELL
|
- |
-266K- 9.96% |
$2.69M - $3.72M
|
2.4M
$0
|
|
|
Nov 14, 2023
Q3 2023
|
Great Point Partners LLC
Greenwich, CT |
SELL
|
- |
-285K- 8.47% |
$2.89M - $3.99M
|
3.08M
$0
|
|
|
Nov 14, 2023
Q3 2023
|
Avidity Partners Management LP
Dallas, TX |
SELL
|
- |
-401K- 37.9% |
$4.06M - $5.61M
|
657K
$0
|
|
|
Nov 14, 2023
Q3 2023
|
Omega Fund Management, LLC
Boston, MA |
SELL
|
- |
-1.88M- 92.43% |
$19M - $26.2M
|
154K
$0
|